Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
What else might be impacted
It is investigational and is being studied in Eli Lilly's Phase 3 TRIUMPH (obesity-focused) and TRANSCEND-T2D (type 2 diabetes) programs
Specifically, the FDA has approved semaglutide for adults who are clinically obese (BMI of 30 or higher) or overweight (BMI of 27 or higher) when accompanied by at least one weight-related health condition, such as hypertension, hyperlipidemia, cardiovascular disease, prediabetes, or obstructive sleep apnea
George Bakris, who was involved in a trial of semaglutide in people with Type 2 diabetes and chronic kidney disease that was backed by Novo Nordisk
Understanding this is essential before you choose
US$ 28.51
US$ 22.11
US$ 26.18
US$ 24.38
US$ 28.11
US$ 23.30
US$ 26.82
US$ 29.52
